Substance P-Derived Peptide Eye Drops Heal Corneal Wounds Through NK-1 Receptor and Akt Signaling
Peptides FGLM-NH2 (from substance P) and SSSR (from IGF-1) promoted corneal wound healing in neurotrophic keratopathy through the NK-1 receptor, Akt signaling, and suppression of inflammatory cytokines.
Quick Facts
What This Study Found
FGLM-NH2 and SSSR promoted corneal epithelial healing through the substance P-NK-1R axis, activating Akt signaling and suppressing inflammatory cytokines IL-1α, MIP-1α, and MIP-1β. NK-1R antagonist L-733,060 abolished the healing effect.
Key Numbers
FGLM-NH2 promoted corneal healing; NK1R knockout or antagonism abolished the effect completely.
How They Did This
Mouse model of neurotrophic keratopathy via trigeminal nerve axotomy. Corneal healing tracked by fluorescein staining and slit-lamp examination. Immunohistofluorescence for substance P, NK-1R, and phospho-Akt. Multiplex cytokine assay for inflammatory markers.
Why This Research Matters
Neurotrophic keratopathy is a sight-threatening condition with limited treatments. Understanding the specific receptor and signaling mechanism of these peptide eye drops supports their clinical development and optimization.
The Bigger Picture
Peptide-based eye drops represent a growing frontier in ophthalmology. This mechanistic understanding of how substance P derivatives promote corneal healing could lead to optimized formulations for a condition that currently has few effective treatments.
What This Study Doesn't Tell Us
Mouse model of neurotrophic keratopathy may not fully replicate human disease. Specific doses and treatment duration details not fully characterized. Long-term effects and optimal treatment protocols need further study.
Questions This Raises
- ?Can these peptide eye drops be advanced to human clinical trials for neurotrophic keratopathy?
- ?Would combining FGLM-NH2/SSSR with other corneal healing agents provide additive benefit?
- ?Do patients with different causes of neurotrophic keratopathy respond equally to this treatment?
Trust & Context
- Key Stat:
- NK-1R receptor identified as the key mediator of peptide-driven corneal wound healing
- Evidence Grade:
- Well-designed animal study with clear mechanistic evidence using receptor antagonist controls. Pre-clinical stage.
- Study Age:
- Published in 2020. Peptide-based corneal therapies continue to advance toward clinical application.
- Original Title:
- Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.
- Published In:
- Investigative ophthalmology & visual science, 61(8), 29 (2020)
- Authors:
- Yanai, Ryoji, Nishida, Teruo(2), Hatano, Makoto, Uchi, Sho-Hei, Yamada, Naoyuki, Kimura, Kazuhiro
- Database ID:
- RPEP-05212
Evidence Hierarchy
Frequently Asked Questions
What is neurotrophic keratopathy?
A condition where damage to the trigeminal nerve impairs the cornea's ability to sense and heal itself, potentially leading to ulcers, scarring, and vision loss.
How do peptide eye drops differ from regular eye drops?
Peptide eye drops contain specific protein fragments that actively signal cells to heal, rather than just moisturizing or reducing inflammation like conventional drops.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05212APA
Yanai, Ryoji; Nishida, Teruo; Hatano, Makoto; Uchi, Sho-Hei; Yamada, Naoyuki; Kimura, Kazuhiro. (2020). Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.. Investigative ophthalmology & visual science, 61(8), 29. https://doi.org/10.1167/iovs.61.8.29
MLA
Yanai, Ryoji, et al. "Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.." Investigative ophthalmology & visual science, 2020. https://doi.org/10.1167/iovs.61.8.29
RethinkPeptides
RethinkPeptides Research Database. "Role of the Neurokinin-1 Receptor in the Promotion of Cornea..." RPEP-05212. Retrieved from https://rethinkpeptides.com/research/yanai-2020-role-of-the-neurokinin1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.